From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

DT-PACE refers to a chemotherapy regimen for multiple myeloma consisting of Dexamethasone, Thalidomide, Cisplatin or Platinol, Adriamycin or doxorubicin, Cyclophosphamide, and Etoposide. [1]


  1. ^ Lee CK, Barlogie B, Munshi N, Zangari M, Fassas A, Jacobson J, van Rhee F, Cottler-Fox M, Muwalla F, Tricot G (2003). "DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma". J Clin Oncol. 21: 2732–9. doi:10.1200/JCO.2003.01.055. PMID 12860952.CS1 maint: Multiple names: authors list (link)

External links[edit]